Beschreibung
Inhaltsangabe1. Introduction to Viral Vectors James N. Warnock, Claire Daigre, and Mohamed Al-Rubeai 2. Introduction to Gene Therapy: A Clinical Aftermath Patrice P. Denèfle 3. Host Cells and Cell Banking Glyn N. Stacey and Otto-Wilhelm Merten 4. Overview of Current Scalable Methods for Purification of Viral Vectors María Mercedes Segura, Amine Kamen, and Alain Garnier 5. Methods to Construct Recombinant Adenovirus Vectors Miguel Chillon and Ramon Alemany 6. Manufacturing of Adenoviruses Vectors: Production and Purification of Helper Dependent Adenovirus Edwige Dormond and Amine A. Kamen 7. Manufacturing of Retroviruses Pedro E. Cruz, Teresa Rodrigues, Marlene Carmo, Dagmar Wirth, Ana Amaral, Paula M. Alves, and Ana S. Coroadinha 8. Lentiviral Vectors Marc Giry-Laterrière, Els Verhoeyen, and Patrick Salmon 9. Adeno-Associated Viruses Mauro Mezzina and Otto-Wilhelm Merten 10. Manufacturing of Adeno-Associated Viruses, for Example: AAV2 Haifeng Chen 11. Vector Characterization Methods for Quality Control Testing of Recombinant Adeno-Associated Viruses J. Fraser Wright and Olga Zelenaia 12. Baculoviruses Mediate Efficient Gene Expression in a Wide Range of Vertebrate Cells Kari J. Airenne, Kaisa-Emilia Makkonen, Anssi J. Mähönen, and Seppo Ylä-Herttuala 13. Herpes Simplex Virus Type 1 (HSV-1)-Derived Recombinant and Amplicon Vectors Cornel Fraefel, Peggy Marconi, and Alberto L. Epstein 14. Manufacture of Measles Viruses Kirsten K. Langfield, Henry J. Walker, Linda C. Gregory, and Mark J. Federspiel 15. In Vivo Gene Delivery into hCD34+ Cells in a Humanized Mouse Model Cecilia Frecha, Floriane Fusil, François-Loïc Cosset, and Els Verhoeyen 16. In Vivo Evaluation of Gene Transfer into Mesenchymal Cells (in View of Cartilage Repair) Kolja Gelse and Holm Schneider 17. Ethical Consideration Michael Fuchs 18. Clinical Trials of GMP Products in the Gene Therapy Field Kathleen B. Bamford
